# Shionogi Pharma Co., Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/shionogi-pharma-co-ltd/97a7893d-fd4c-45bc-9237-0e03e7d8af7c

> Inspection records and compliance data for Shionogi Pharma Co., Ltd. in Settsu, None. Access full analysis and detailed observations.

---

## Details

- Name: Shionogi Pharma Co., Ltd.
- FEI Number: 3004544937
- City: Settsu
- State: None
- Country Name: Japan
- Address Line 1: 2 Chome 5-1, Mishima
- Zip Code: None

## Related Documents

- [483 - Shionogi Pharma Co., Ltd. - 2025-09-20](https://www.globalkeysolutions.net/records/483/shionogi-pharma-co-ltd/98b7e68d-83a4-4954-8f8a-0837f8c42dad) — source: FDA, date: September 20, 2025
- [483 - Shionogi Pharma Co., Ltd. - 2025-05-30](https://www.globalkeysolutions.net/records/483/shionogi-pharma-co-ltd/833daad8-0cfb-4648-9bda-947515be328d) — source: FDA, date: May 30, 2025
- [FDA Inspection 1275572 - Shionogi Pharma Co., Ltd. - 2025-05-30](https://www.globalkeysolutions.net/records/fda_inspections/shionogi-pharma-co-ltd/9e613c93-0b14-40d7-91c2-c706443008d9) — source: FDA, date: May 30, 2025
- [FDA Inspection 1275572 - Shionogi Pharma Co., Ltd. - 2025-05-30](https://www.globalkeysolutions.net/records/fda_inspections/shionogi-pharma-co-ltd/0f2b730c-1b47-40b2-a948-b51f76eeb900) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2025
- [FDA Inspection 1084840 - Shionogi Pharma Co., Ltd. - 2019-02-28](https://www.globalkeysolutions.net/records/fda_inspections/shionogi-pharma-co-ltd/21241797-35d6-4c0a-86a6-b552c48af767) — classification: No Action Indicated (NAI), source: FDA, date: February 28, 2019

## Related Companies

- [Nippon Fine Chemical Co., Ltd.](https://www.globalkeysolutions.net/companies/nippon-fine-chemical-co-ltd/6b21c73b-4779-42c3-b0f6-64179f8de3a2)
- [Unilever Manufacturing (US), Inc.](https://www.globalkeysolutions.net/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6)
- [Apertus Pharmaceuticals](https://www.globalkeysolutions.net/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155)
- [Chugai Pharmaceutical Co., Ltd.](https://www.globalkeysolutions.net/companies/chugai-pharmaceutical-co-ltd/5261bb2e-233a-40e3-8aa3-3e7b0b70dd29)
- [BRS Analytical Services, LLC](https://www.globalkeysolutions.net/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528)
- [Valneva Scotland Ltd.](https://www.globalkeysolutions.net/companies/valneva-scotland-ltd/7e6970c2-c9dd-4c5d-9d35-725121b6e877)
- [Aurobindo Pharma Limited](https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/95bcc3b3-09a1-4249-af2f-5c83de789b76)
- [Lilly del Caribe, Inc](https://www.globalkeysolutions.net/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073)
- [Pyramid Laboratories, Inc.](https://www.globalkeysolutions.net/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33)
- [Aurobindo Pharma Limited](https://www.globalkeysolutions.net/companies/aurobindo-pharma-limited/526fd1b4-90b1-4e91-b9f5-a3eab997ed60)

## Related Officers

- [Lillian S. Wu](https://www.globalkeysolutions.net/people/lillian-s-wu/b1f6643c-ac01-43e5-8ce2-e6f4fdba9d35)